LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 84.92 | 771.67 | 4918 | 12266 | 0.4009 | 0.5906 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 84.92 | 771.67 | 10749 | 12266 | 0.8763 | 0.9349 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.14 | 771.67 | 4495 | 12592 | 0.3570 | 0.5487 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.14 | 771.67 | 11099 | 12592 | 0.8814 | 0.9383 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 2.49 | 771.67 | 928 | 867 | 1.0694 | 1.9732 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 2.49 | 771.67 | 990 | 867 | 1.1409 | 3.3565 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 4.71 | 771.67 | 1006 | 956 | 1.0519 | 1.3550 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 4.71 | 771.67 | 1108 | 956 | 1.1585 | 2.2171 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 6.94 | 771.67 | 1091 | 1045 | 1.0439 | 1.2063 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 6.94 | 771.67 | 1174 | 1045 | 1.1233 | 1.6087 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 9.16 | 771.67 | 1170 | 1138 | 1.0277 | 1.0997 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 9.16 | 771.67 | 1283 | 1138 | 1.1269 | 1.4747 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 11.56 | 771.67 | 1317 | 1280 | 1.0284 | 1.0781 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 11.56 | 771.67 | 1418 | 1280 | 1.1073 | 1.2993 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 13.78 | 771.67 | 1441 | 1459 | 0.9872 | 0.9721 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 13.78 | 771.67 | 1540 | 1459 | 1.0550 | 1.1198 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.00 | 771.67 | 1566 | 1585 | 0.9877 | 0.9763 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.00 | 771.67 | 1658 | 1585 | 1.0457 | 1.0880 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.22 | 771.67 | 1619 | 1741 | 0.9297 | 0.8797 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.22 | 771.67 | 1736 | 1741 | 0.9969 | 0.9947 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 20.44 | 771.67 | 1588 | 1910 | 0.8310 | 0.7361 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 20.44 | 771.67 | 1756 | 1910 | 0.9190 | 0.8749 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 22.66 | 771.67 | 1637 | 2141 | 0.7644 | 0.6665 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 22.66 | 771.67 | 1801 | 2141 | 0.8410 | 0.7781 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.89 | 771.67 | 1686 | 2397 | 0.7032 | 0.6126 | MN20160304_L01 | I13 |